Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia
Conditions: Hypertension; Dyslipidemias Interventions: Drug: Olostar Tab (olmesartan/rosuvastatin FDC(fixed dose combination)); Drug: Two separated drugs(ARB(Angiotensin Ⅱ receptor blocker) and statin) Sponsor: Yonsei University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials